Drug profile · INN
pioglitazone hydrochloride
PIOGLITAZONE HYDROCHLORIDE
pioglitazone hydrochloride (PIOGLITAZONE HYDROCHLORIDE) is a peroxisome proliferator-activated receptor gamma agonist. Associated with Takeda. Route of administration: oral. Current US regulatory status: approved.
Drug details — pioglitazone hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 20
- Programs
- 64
- Data quality
- 0.89
Quick answer
pioglitazone hydrochloride (PIOGLITAZONE HYDROCHLORIDE) is a peroxisome proliferator-activated receptor gamma agonist. Associated with Takeda. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Peroxisome proliferator-activated receptor gamma agonist
Primary target: Peroxisome proliferator-activated receptor gamma
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 12385026
Stabilized alpha-galactosidase and uses thereof
granted -
US 12268700
3-o-sulfo-galactosylceramide analogs as activators of type II NKT cells and uses thereof
granted -
US 12194079
Therapeutic regimen for the treatment of Fabry using stabilized alpha-galactosidase
granted -
US 11396571
Polymers including galactose based blocks and uses thereof
granted -
US 11116823
Treatment of α-galactosidase a deficiency
granted -
US 10870842
Stabilized alpha-galactosidase and uses thereof
granted -
US 10744154
Galactose-pronged polysaccharides in a formulation for antifibrotic therapies
granted -
US 10280414
Stabilized α-galactosidase and uses thereof
granted -
US 10253294
Galactose oxidase treatment of dendritic cells to improve their immunogenicity
granted -
US 9796756
Galactose cluster-pharmacokinetic modulator targeting moiety for siRNA
granted -
US 9732333
Nucleic acid construct for expression of alpha-galactosidase in plants and plant cells
granted -
US 9708595
Stabilized alpha-galactosidase and uses thereof
granted -
US 9567572
Manufacture of active highly phosphorylated human N-acetylgalactosamine-6-sulfatase and uses thereof
granted -
US 9320714
Tablet
granted -
US 9249179
Galactose cluster-pharmacokinetic modulator targeting moiety for siRNA
granted -
US 9200090
Galactose-pronged polysaccharides in a formulation for antifibrotic therapies
granted -
US 9194011
Stabilized alpha-galactosidase and uses thereof
granted -
US 9101660
Solid preparation
granted -
US 8940513
Manufacture of active highly phosphorylated human N-acetylgalactosamine-6-sulfatase and uses thereof
granted -
US 8865217
Oral preparation comprising pioglitazone
granted
Frequently asked questions
What is pioglitazone hydrochloride?
pioglitazone hydrochloride (PIOGLITAZONE HYDROCHLORIDE) is a peroxisome proliferator-activated receptor gamma agonist. Associated with Takeda. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for pioglitazone hydrochloride?
PIOGLITAZONE HYDROCHLORIDE is a marketed brand name for pioglitazone hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of pioglitazone hydrochloride?
pioglitazone hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.